|
1
|
Hu KQ: Advances in clinical application of
cryoablation therapy for hepatocellular carcinoma and metastatic
liver tumor. J Clin Gastroenterol. 48:830–836. 2014.PubMed/NCBI
|
|
2
|
Maluccio M and Covey A: Recent progress in
understanding, diagnosing, and treating hepatocellular carcinoma.
CA Cancer J Clin. 62:394–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Farazi PA and DePinho RA: The genetic and
environmental basis of hepatocellular carcinoma. Discov Med.
6:182–186. 2006.
|
|
4
|
Lencioni R: Loco-regional treatment of
hepatocellular carci noma. Hepatology. 52:762–773. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sheen AJ and Siriwardena AK: The end of
cryotherapy for the treatment of nonresectable hepatic tumors? Ann
Surg Oncol. 12:202–204. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hutchinson M, Shyn P and Silverman S:
Cryoablation of Liver Tumors. Image-Guided Cancer Therapy. Dupuy
DE, Fong Y and McMullen WN: Springer; New York: pp. 491–503. 2013,
View Article : Google Scholar
|
|
7
|
Ling S, Tian Y, Zhang H, Jia K, Feng T,
Sun D, Gao Z, Xu F, Hou Z, Li Y, et al: Metformin reverses
multidrug resistance in human hepatocellular carcinoma
Bel-7402/5-fluorouracil cells. Mol Med Rep. 10:2891–2897.
2014.PubMed/NCBI
|
|
8
|
Alix-Panabières C and Pantel K:
Circulating tumor cells: Liquid biopsy of cancer. Clin Chem.
59:110–118. 2013. View Article : Google Scholar
|
|
9
|
Nguyen DX, Bos PD and Massagué J:
Metastasis: From dissemination to organ-specific colonization. Nat
Rev Cancer. 9:274–284. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kang Y and Pantel K: Tumor cell
dissemination: Emerging biological insights from animal models and
cancer patients. Cancer Cell. 23:573–581. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gorges TM and Pantel K: Circulating tumor
cells as therapy-related biomarkers in cancer patients. Cancer
Immunol Immunother. 62:931–939. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lianidou ES, Markou A and Strati A:
Molecular characterization of circulating tumor cells in breast
cancer: Challenges and promises for individualized cancer
treatment. Cancer Metastasis Rev. 31:663–671. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hou JM, Greystoke A, Lancashire L,
Cummings J, Ward T, Board R, Amir E, Hughes S, Krebs M, Hughes A,
et al: Evaluation of circulating tumor cells and serological cell
death biomarkers in small cell lung cancer patients undergoing
chemotherapy. Am J Pathol. 175:808–816. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Krebs MG, Sloane R, Priest L, Lancashire
L, Hou JM, Greystoke A, Ward TH, Ferraldeschi R, Hughes A, Clack G,
et al: Evaluation and prognostic significance of circulating tumor
cells in patients with non-small-cell lung cancer. J Clin Oncol.
29:1556–1563. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cristofanilli M, Budd GT, Ellis MJ,
Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ,
Terstappen LW, et al: Circulating tumor cells, disease progression,
and survival in metastatic breast cancer. N Engl J Med.
351:781–791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hayes DF, Cristofanilli M, Budd GT, Ellis
MJ, Stopeck A, Miller MC, Matera J, Allard WJ, Doyle GV and
Terstappen LW: Circulating tumor cells at each follow-up time point
during therapy of metastatic breast cancer patients predict
progression-free and overall survival. Clin Cancer Res.
12:4218–4224. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cohen SJ, Punt CJ, Iannotti N, Saidman BH,
Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC, et
al: Relationship of circulating tumor cells to tumor response,
progression-free survival, and overall survival in patients with
metastatic colorectal cancer. J Clin Oncol. 26:3213–3221. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
de Bono JS, Scher HI, Montgomery RB,
Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ
and Raghavan D: Circulating tumor cells predict survival benefit
from treatment in metastatic castration-resistant prostate cancer.
Clin Cancer Res. 14:6302–6309. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pantel K, Brakenhoff RH and Brandt B:
Detection, clinical relevance and specific biological properties of
disseminating tumour cells. Nat Rev Cancer. 8:329–340. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cristofanilli M: Circulating tumor cells,
disease progression, and survival in metastatic breast cancer.
Semin Oncol. 33(Suppl 9): S9–S14. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu KC, Niu LZ, He WB, Hu YZ and Zuo JS:
Percutaneous cryosurgery for the treatment of hepatic colorectal
metastases. World J Gastroenterol. 14:1430–1436. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Niu LZ, Li JL and Xu KC: Percutaneous
cryoablation for liver cancer. J Clin Transl Hepatol. 2:182–188.
2014.
|
|
23
|
Lin CH, Chao LK, Hung PH and Chen YJ: EGCG
inhibits the growth and tumorigenicity of nasopharyngeal
tumor-initiating cells through attenuation of STAT3 activation. Int
J Clin Exp Pathol. 7:2372–2381. 2014.PubMed/NCBI
|
|
24
|
Hussein YM, Ghareib AF, Mohamed RH, Radwan
MI and Elsawy WH: MAGE-3 and MAGE-4 genes as possible markers for
early detection of metastases in hepatitis C virus Egyptian
patients complicated by hepatocellular carcinoma. Med Oncol.
29:994–999. 2012. View Article : Google Scholar
|
|
25
|
Hu Y, Fan L, Zheng J, Cui R, Liu W, He Y,
Li X and Huang S: Detection of circulating tumor cells in breast
cancer patients utilizing multiparameter flow cytometry and
assessment of the prognosis of patients in different CTCs levels.
Cytometry A. 77:213–219. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kodera Y, Nakanishi H, Ito S, Yamamura Y,
Kanemitsu Y, Shimizu Y, Hirai T, Yasui K, Kato T and Tatematsu M:
Quantitative detection of disseminated free cancer cells in
peritoneal washes with real-time reverse transcriptase-polymerase
chain reaction: A sensitive predictor of outcome for patients with
gastric carcinoma. Ann Surg. 235:499–506. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
28
|
Poon RT and Fan ST: Hepatectomy for
hepatocellular carcinoma: Patient selection and postoperative
outcome. Liver Transpl. 10(Suppl 1): S39–S45. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ng KK, Lo CM, Chan SC, Chok KS, Cheung TT
and Fan ST: Liver transplantation for hepatocellular carcinoma: The
Hong Kong experience. J Hepatobiliary Pancreat Sci. 17:548–554.
2010. View Article : Google Scholar
|
|
30
|
Gutman S and Kessler LG: The US Food and
Drug Administration perspective on cancer biomarker development.
Nat Rev Cancer. 6:565–571. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Soresi M, Magliarisi C, Campagna P, Leto
G, Bonfissuto G, Riili A, Carroccio A, Sesti R, Tripi S and
Montalto G: Usefulness of alpha-fetoprotein in the diagnosis of
hepatocellular carcinoma. Anticancer Res. 23:1747–1753.
2003.PubMed/NCBI
|
|
32
|
Sanai FM, Sobki S, Bzeizi KI, Shaikh SA,
Alswat K, Al-Hamoudi W, Almadi M, Al Saif F and Abdo AA: Assessment
of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma
in Middle Eastern patients. Dig Dis Sci. 55:3568–3575. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Saad F and Pantel K: The current role of
circulating tumor cells in the diagnosis and management of bone
metastases in advanced prostate cancer. Future Oncol. 8:321–331.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Franke WW, Schmid E, Osborn M and Weber K:
Intermediate-sized filaments of human endothelial cells. J Cell
Biol. 81:570–580. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kakehashi A, Kato A, Inoue M, Ishii N,
Okazaki E, Wei M, Tachibana T and Wanibuchi H: Cytokeratin 8/18 as
a new marker of mouse liver preneoplastic lesions. Toxicol Appl
Pharmacol. 242:47–55. 2010. View Article : Google Scholar
|
|
36
|
Tsuchiya K, Komuta M, Yasui Y, Tamaki N,
Hosokawa T, Ueda K, Kuzuya T, Itakura J, Nakanishi H, Takahashi Y,
et al: Expression of keratin 19 is related to high recurrence of
hepatocellular carcinoma after radiofrequency ablation. Oncology.
80:278–288. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Racila E, Euhus D, Weiss AJ, Rao C,
McConnell J, Terstappen LW and Uhr JW: Detection and
characterization of carcinoma cells in the blood. Proc Natl Acad
Sci USA. 95:4589–4594. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pachmann K, Heiss P, Demel U and Tilz G:
Detection and quantification of small numbers of circulating tumour
cells in peripheral blood using laser scanning cytometer (LSC).
Clin Chem Lab Med. 39:811–817. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Whiteside TL: What are regulatory T cells
(Treg) regulating in cancer and why? Semin Cancer Biol. 22:327–334.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Misao A, Sakata K, Saji S and Kunieda T:
Late appearance of resistance to tumor rechallenge following
cryosurgery. A study in an experimental mammary tumor of the rat.
Cryobiology. 18:386–389. 1981. View Article : Google Scholar : PubMed/NCBI
|
